HSICHenry Schein

Health care · Medical Distribution · Nasdaq

Henry Schein, Inc. is a solutions company for health care professionals powered by a network of people and technology. 10-K, Item 1

Employees: 25,000
Headquarters: Melville, NY
CEO: Stanley M. Bergman
Next results: around Feb 23, 2027

Compare with peers → Embed

The numbers HSIC said it expected, in its earnings releases of the last 3 years, next to what it then reported for the same period. Each target links to the sentence in the release; each result to the 10-Q or 10-K it was first reported in.

Target	What the company said	Reported	Result
Diluted EPS (company-defined) Fiscal 2026	Given $5.23 release 2026-02-24 Raised $5.29 to $5.39 release 2026-08-04	–	No standard number
The company's words 2026 non-GAAP diluted EPS expected to be in the range of $5.23 release 2026-02-24 Raises guidance for 2026 to the following: non-GAAP diluted EPS to $5.29 to $5.39, Adjusted EBITDA growth release 2026-08-04
Diluted EPS (company-defined) Fiscal 2025 (ended 2025-12-27)	Given $4.80 release 2025-02-25 Kept $4.80 release 2025-05-05 Raised $4.80 to $4.94 release 2025-08-05 Raised $4.88 to $4.96 release 2025-11-04	–	No standard number
The company's words 2025 non-GAAP diluted EPS expected to be in the range of $4.80 release 2025-02-25 Maintains guidance for 2025 non-GAAP diluted EPS of $4.80 to release 2025-05-05 Maintains guidance for 2025 non-GAAP diluted EPS of $4.80 to $4.94, mid-single digit 2025 Adjusted release 2025-08-05 Raises 2025 guidance for non-GAAP diluted EPS to $4.88 to $4.96 and sales release 2025-11-04
Diluted EPS (company-defined) Fiscal 2024 (ended 2024-12-28)	Given $5.00 to $5.16 release 2024-02-27 Kept $5.00 to $5.16 release 2024-05-07 Lowered $4.70 to $4.82 release 2024-08-06 Raised $4.74 to $4.82 release 2024-11-05	–	No standard number
The company's words Introduces guidance for full-year 2024 non-GAAP diluted EPS of $5.00 to $5.16, release 2024-02-27 Affirms 2024 non-GAAP diluted EPS guidance of $5.00 to $5.16 and 2024 Adjusted EBITDA growth of more release 2024-05-07 2024 full-year non-GAAP EPS guidance updated to $4.70 to $4.82 release 2024-08-06 Increases 2024 full-year non-GAAP EPS guidance to $4.74 to $4.82 from $4.70 to $4.82 release 2024-11-05
Diluted EPS (company-defined) Fiscal 2023 (ended 2023-12-30)	Given $4.43 to $4.71 release 2023-11-13	–	No standard number
The company's words 2023 non-GAAP diluted EPS guidance of $4.43 to $4.71 updated release 2023-11-13

Targets are read from the sentences of the EX-99 exhibits of 8-K item 2.02 filings (14 releases since 2023-11-13), without AI; in outlook tables only the first column is read. The result compares the reported number with the last range given before the period was reported. Results come from SEC's XBRL company facts, as first reported. A company's target can use its own definition (META's capital expenditures include finance lease payments, for example), so read the quote.

Work on HSIC in a spreadsheet: Excel workbook (a sheet per section, ten years by column, charts, links to the filings) · CSV. For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/HSIC/export.csv") into a cell.